Booster Immunisation with Skin-Patch-Delivered Unadjuvanted SARS-CoV-2 Spike Protein Vaccine Is Safe and Immunogenic in Healthy Adults

Background/Objective: Despite available SARS-CoV-2 vaccines, coverage gaps persist due to unequal distribution and limited access. Microarray patches offer a promising solution to address these challenges, providing a safer and easier-to-use alternative. We present a randomised, double-blind Phase I...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Christopher L. D. McMillan, David A. Muller, Germain J. P. Fernando, Alexandra C. I. Depelsenaire, Cesar Jayashi-Flores, Kelly-Anne Masterman, Sarika Namjoshi, Kartik Vyas, Deborah Pascoe, Julian Hickling, Stephanie Wallace, Daniel Duijsings, Joelle Vink, Adam K. Wheatley, Jennifer Juno, Greg Siller, Angus H. Forster
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	MDPI AG 2025-12-01
Rangatū:	Vaccines
Ngā marau:	microarray patch microneedles SARS-CoV-2 HexaPro phase 1 clinical trial thermostable vaccine
Urunga tuihono:	https://www.mdpi.com/2076-393X/14/1/28
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!